This paper evaluates the clinical, radiological and histomorphologic effect of neoadjuvant chemotherapy in 37 patients with II B osteosarcomas. The results are compared according to the type of surgery, local recurrence and lung metastasis at a minimal follow up of five years in patients who underwent surgery at the orthopedic clinic in Prague Bulovka in 1982 - 1992. All patients continued with adjuvant chemotherapy after surgery. Bad clinical response (increase of circumference, decrease in range of motion and increase of pain) correlated with the bad histologic response evaluated according to the COSS criteria. Accurate evaluation of a complete radiological documentation (tumor calcification on plain radiographs and CT scans, decrease of tumor volume on plain radiographs and CT scans or MRI and the disappearance of pathologic vascularisation) can quite precisely estimate a good response to preoperative chemotherapy and indicate limb sparing surgery. The radiological evaluation, especially of an incomplete record, does not always fully correlate with the histomorphologic response. Good prognosis for long term survival was observed in patients with a more then 80% tumor cell necrosis. CT scans or MRI performed immediately before the beginning and at the end of preoperative chemotherapy are necessary for a reliable evaluation of tumor calcification and intramedullar tumor spread. The persistence or disappearance of pathologic vascularisation seems to be the most significant marker to evaluate residual vital tumor cells. A good radiological response enables a safe indication for a limb sparing procedure as an alternative to amputation. The radiological evaluation must be correlated with different histomorphologic osteosarcoma subtypes as well as with possible changes, especially in vascularisation, due to an incorrect biopsy or pathologic fracture. Key words: osteosarcoma, neoadjuvant chemotherapy, long term survival, indication for limb salvage.
Download full-text PDF |
Source |
---|
Prostate Int
December 2024
Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea.
Background: We investigated whether combining T2-weighted magnetic resonance imaging (MRI) findings and clinical risk categories improves upon established prognostic indicators of oncological outcomes in prostate cancer.
Methods: Patients who underwent radical prostatectomy, but not preoperative hormone therapy, radiotherapy, or chemotherapy, for localized prostate cancer at Seoul National University Bundang Hospital from October 2007 to April 2016 were included. MRIs were classified according to the Prostate Imaging-Reporting and Data System (PI-RADS).
Turk J Med Sci
December 2024
Department of Surgery, Division of General Surgery, Faculty of Medicine, İstanbul University, İstanbul, Turkiye.
Background/aim: Mucinous breast carcinoma (MBC) is thought to be a favorable-differentiated form of invasive breast cancer and is rarely preferred for neoadjuvant chemotherapy (NAC). The study aimed to define the response of MBCs to NAC.
Materials And Methods: A review was made of the demographic, clinicopathologic characteristics, management and follow-up data of 70 patients diagnosed with MBC between May 2010 and December 2020 by examining the patients' historical files and oncology records.
J Surg Oncol
December 2024
Department of Esophageal Surgery, National Cancer Center Hospital East, Chiba, Japan.
Backgrounds: Currently, there is a lack of evidence of prehabilitation during neoadjuvant chemotherapy (NAC) to prevent pneumonia of older patients. This study aimed to investigate the association of preoperative physical fitness after NAC with post-esophagectomy pneumonia in older patients with locally advanced esophageal cancer (LAEC).
Methods: This single-center exploratory prospective cohort study included 80 patients aged ≥ 65 years with LAEC scheduled for curative esophagectomy after NAC between 2021 and 2023.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
January 2025
Intrathyroid thymic carcinoma(ITTC) is a rare thyroid tumor that lacks typical clinical manifestations and imaging features, making preoperative diagnosis challenging.The primary treatment for ITTC is radical surgery; however, the effectiveness of adjuvant radiotherapy and chemotherapy post-surgery is not well-established. This paper presents a case of ITTC , analyzing the clinical data and correlating it with the literature to explore the clinical manifestations, diagnostic approach, treatment, and prognosis of ITTC.
View Article and Find Full Text PDFClin Breast Cancer
December 2024
Faculty of Medicine, Health and Life Science, Swansea University, Wales, United Kingdom.
Background: Adjuvant therapy decisions in hormone receptor positive, HER2 negative breast cancer are evolving. Gene panel testing has reduced the number of patients recommended for chemotherapy by up to two thirds. Identifying low risk genomic cases before testing could represent a significant economic impact.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!